Literature DB >> 9729323

Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury.

E J Beilharz1, V C Russo, G Butler, N L Baker, B Connor, E S Sirimanne, M Dragunow, G A Werther, P D Gluckman, C E Williams, A Scheepens.   

Abstract

Insulin-like growth factor 1 (IGF-1) is induced after hypoxic-ischemic (HI) brain injury, and therapeutic studies suggest that IGF-1 may restrict delayed neuronal and glial cell loss. We have used a well-characterised rat model of HI injury to extend our understanding of the modes of action of the IGF system after injury. The induction of the IGF system by injury was examined by in situ hybridization, immunohistochemistry, Northern blot analysis, RNase protection assay and reverse transcriptase-polymerase chain reaction (RT-PCR). IGF-1 accumulated in blood vessels of the damaged hemisphere within 5 h after a severe injury. By 3 days, IGF-1 mRNA was expressed by reactive microglia in regions of delayed neuronal death, and immunoreactive IGF-1 was associated with these microglia and reactive astrocytes juxtaposed to surviving neurones surrounding the infarct. Total IGF-1 receptor mRNA was unchanged by the injury. IGFBP-2 mRNA was strongly induced in reactive astrocytes throughout the injured hemisphere, and IGFBP-3 and IGFBP-5 mRNA were moderately induced in reactive microglia and neurones of the injured hippocampus, respectively. IGFBP-6 mRNA was induced in the damaged hemisphere by 3 days and increased protein was seen on the choroid plexus, ependyma and reactive glia. In contrast, insulin II was not induced. These results indicate cell type-specific expression for IGF-1, IGFBP-2,3,5 and 6 after injury. Our findings suggest that the IGF-1 produced by microglia after injury is transferred to perineuronal reactive astrocytes expressing IGFBP-2. Thus, modulation of IGF-1 action by IGFBP-2 might represent a key mechanism that restricts neuronal cell loss following HI brain injury. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729323     DOI: 10.1016/s0169-328x(98)00122-3

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  46 in total

Review 1.  Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1.

Authors:  S A Loddick; N J Rothwell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 2.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

3.  Therapeutic potential of IGF-I on hippocampal neurogenesis and function during aging.

Authors:  Gustavo R Morel; Micaela López León; Maia Uriarte; Paula C Reggiani; Rodolfo G Goya
Journal:  Neurogenesis (Austin)       Date:  2016-12-20

4.  Insulin-like Growth Factor Binding Protein6 Associated with Neuronal Apoptosis Following Intracerebral Hemorrhage in Rats.

Authors:  Qijun Dai; Peipei Jiang; Yang Gu; Lin Zhu; Haifeng Dai; Zhigang Yao; Hua Liu; Xiaoping Ma; Chengwei Duan; Lianxia Qu
Journal:  Cell Mol Neurobiol       Date:  2017-01-02       Impact factor: 5.046

5.  Spatiotemporal Regulation of Insulin-Like Growth Factor-1 and Its Receptor in the Brain: Is There a Role for Growth Hormone?

Authors:  Sarah M Gray; Michael O Thorner
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

Review 6.  Cell death in the nervous system: lessons from insulin and insulin-like growth factors.

Authors:  Isabel Varela-Nieto; Enrique J de la Rosa; Ana I Valenciano; Yolanda León
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

7.  Neuroprotective effects of IGF-I following kainic acid-induced hippocampal degeneration in the rat.

Authors:  Panagiota Miltiadous; Antonios Stamatakis; Fotini Stylianopoulou
Journal:  Cell Mol Neurobiol       Date:  2009-09-24       Impact factor: 5.046

8.  Growth hormone deficiency and cerebral palsy.

Authors:  Jesús Devesa; Nerea Casteleiro; Cristina Rodicio; Natalia López; Pedro Reimunde
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

9.  Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy.

Authors:  Pedro Reimunde; Cristina Rodicio; Natalia López; Alba Alonso; Pablo Devesa; Jesús Devesa
Journal:  Ther Clin Risk Manag       Date:  2010-11-30       Impact factor: 2.423

10.  Comparison of gene expression during in vivo and in vitro postnatal retina development.

Authors:  Mu-Gen Liu; Hong Li; Xuming Xu; Colin J Barnstable; Samuel Shao-Min Zhang
Journal:  J Ocul Biol Dis Infor       Date:  2008-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.